Ingredient science, clinical evidence, and respiratory health education
Product analysis and respiratory health research from breathizen.cc. Each article covers a specific ingredient mechanism, clinical study, or respiratory health topic with referenced evidence.
BreathiZen addresses airway congestion through two distinct mucociliary mechanisms, not one. Mullein saponins and Bromelain act on separate layers of bronchial mucus stiffening.
Cordyceps cordycepin acts as a partial A2B receptor agonist on bronchial smooth muscle. Here's what that means for breathing capacity and why it differs from pharmaceutical bronchodilators.
Mullein leaf has been used for respiratory conditions for centuries. The active fraction, saponins, and how they compare to standard expectorants, with clinical context.
A 2010 randomized trial published in Phytomedicine found Cordyceps supplementation improved VO₂ max by a statistically significant margin in adults over 50. What the study found and what it means.
Chronic bronchial congestion without diagnosed structural disease is underserved by pharmaceutical options. An evidence review of botanical and nutritional approaches.
Bromelain is primarily known for digestive support, but its cysteine protease activity has documented effects on bronchial mucus viscosity and nasal mucosal inflammation. Full mechanism review.
The 2017 BMJ meta-analysis of 25 RCTs (n=11,321) found Vitamin D3 supplementation reduced acute respiratory infection incidence. Who benefited most and why.
Ginger's [6]-gingerol inhibits 5-lipoxygenase, blocking leukotriene B4 production in bronchial tissue. Why this mechanism differs from NSAID anti-inflammatory action.
Rosmarinic acid in Melissa officinalis inhibits complement C3 and C5 convertases and shows in vitro antiviral activity against RSV. Clinical relevance and dose context.
Not all supplement formats deliver ingredients with equal efficiency. The case for oral spray format in respiratory supplement design, specifically for Bromelain and botanical saponins.